betnovate 01 cream 30g tube - search results

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

betnovate 0.1% cream

glaxosmithkline uk ltd - betamethasone valerate - cutaneous cream - 1mg/1gram

New Zealand - English - Medsafe (Medicines Safety Authority)

betnovate c

glaxosmithkline nz limited - betamethasone valerate 0.1%{relative} (0.122% with overage); clioquinol 3%{relative} - topical ointment - active: betamethasone valerate 0.1%{relative} (0.122% with overage) clioquinol 3%{relative} excipient: liquid paraffin white soft paraffin - betnovate-c preparations are indicated for the treatment of the following conditions where secondary bacterial and/or fungal infection is present, suspected or likely to occur:- eczema including atopic, and discoid eczemas. prurigo nodularis. psoriasis (excluding widespread plaque psoriasis). neurodermatoses including lichen simplex, lichen planus. seborrhoeic dermatitis. contact sensitivity reactions. insect bite reactions. prickly heat. anal and genital intertrigo. otitis externa.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

betamethasone valerate 0.1% cream

a a h pharmaceuticals ltd - betamethasone valerate - cutaneous cream - 1mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

betamethasone valerate 0.1% cream

kent pharma (uk) ltd - betamethasone valerate - cutaneous cream - 1mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

betamethasone valerate 0.1% cream

alliance healthcare (distribution) ltd - betamethasone valerate - cutaneous cream - 1mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

betamethasone valerate 0.1% cream

teva uk ltd - betamethasone valerate - cutaneous cream - 1mg/1gram